bpc 157 capsuples BPC-157 – Mark Hyman, MD BPC-157 Body Protective Compound, Maxlife

Tested by independent laboratories for heavy metals, residual solvents, and endotoxins, in line with established limits

Compound 6 is currently under Phase I clinical investigation for pancreatic adenocarcinoma and other selected solid tumors

GHK-Cu works through cumulative tissue exposure, not peak concentration

Insurance : Usually not covered

Not a substitute for diet, exercise, or approved medical therapies for obesity or metabolic disorders

The estimated impacts for some specialties, including clinical social workers and clinical psychologists, anesthesiology and nurse anesthetists, psychiatry, geriatrics, chiropractic, and endocrinology, reflect increases relative to other specialties